The association between telomerase, p53, and clinical staging in colorectal cancer

American Journal of Surgery

Volumn 175, Issue 5, 1998, Pages 364-366

  Brown, Tommy ^a,b   Aldous, Wade ^a,b   Lance, Raymond ^a,b   Blaser, Jason ^a,b   Baker, Thomas ^a,b   Williard, William ^a,b  

^a Madigan Army Medical Center ^*

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TELOMERASE;

AGED; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; BASE SEQUENCE; COLORECTAL NEOPLASMS; ENZYME TESTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031923244     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00057-9     Document Type: Conference Paper

References (12)

1. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820-823.
2. Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short term prognosis. Cancer. 1992;70:2778-2784.
3. Purdie CA, O'Grady J, Piris J, et al. p53 expression in colorectal tumors. Am J Pathol 1991;138:807-813.
4. Zeng Z, Sarkis AS, Zhang Z, et al. p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol. 1994;12:2043-2050.
5. Nathanson SD, Linden MD, Tender P, et al. Relationship among p53, stage, and prognosis of large bowel cancer. Dis Colon Rectum. 1994;37:527-534.
6. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology. 1993;104:57-64.
7. Kim MW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC). 1994;266:2011-2015.
8. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with aquisition of malignancy in human colorectal cancers. Cancer Res. 1995;55:2533-2536.
9. Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res. 1995;1:1245-1251.
10. Wynford-Thomas D, Bond JA, Wyllie FS, Jones CJ. Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinogen. 1995;12:119-123.
11. Sabistan DC Jr, Lyerly HK. Essentials of Surgery. 2nd ed. Philadelphia: WB Saunders; 1994:355.
12. Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1995;1:249-255.